Answers are grounded in this paper and cite their sources.
Large-scale cohort study reveals COVID-19 infection raises autoimmune blistering disease risk, while vaccination lowers it.
BACKGROUND: Numerous diseases associated with COVID-19 infection and vaccination have been reported, including conditions such as the autoimmune blistering diseases (AIBDs) pemphigus and pemphigoid. However, robust evidence supporting these associations is lacking. OBJECTIVE: To investigate the risk of developing AIBD following COVID-19 infection and vaccination. METHODS: Population-based retrospective cohort study utilizing data from over 112 million patients. The risk of AIBD within 3 months was compared among 3 cohorts: COVID-19 infection, COVID-19 vaccination, and controls, along with 7 sensitivity analyses. RESULTS: COVID-19 infection was associated with an increased risk of AIBD (hazard ratio [HR] 1.508, 95% CI 1.260-1.805), with the risk being more pronounced for pemphigus (HR 2.432, 1.618-3.657) compared to bullous pemphigoid (HR 1.376, 1.019-1.857). Conversely, COVID-19 vaccination was associated with an almost halved risk of AIBD (HR 0.514, 0.394-0.672), with the risk reduction most significant for pemphigus (HR 0.477, 0.241-0.946). Comparisons between COVID-19 infection and vaccination revealed a more than threefold increased risk of AIBD in the infection cohort (HR 3.130, 2.411-4.063), particularly for pemphigus (HR 5.508, 2.973-10.205). LIMITATIONS: Retrospective design and potential under-reporting of COVID-19 cases and vaccinations. CONCLUSION: COVID-19 infection significantly increases the risk of AIBD while vaccination appears to reduce this risk.
No takes yet. Share an insight, caveat, or question.
Curman et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: